Bladder Cancer Incidence Trends in the United States From 2000 to 2020
Cancer Reports · 2026-05 · 9 (5)
DOI: 10.1002/cnr2.70548 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, online erschienen am 28.04.2026. Verfasst von Seyed Ehsan Mousavi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Neurosciences Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Bladder cancer is one of the most common urogenital cancers globally. Here, we aimed to report the incidence trend of bladder cancer in the United States (US) over 2000–2020, by age, sex, race/ethnicity, and types using Surveillance, Epidemiology, and End Results (SEER).
Methods
We used SEER 22 data to calculate the age‐standardized and delay‐adjustment incidence rate of bladder cancer. Only individuals diagnosed with cancer and whose age at diagnosis was known were included in the study. A delay model was applied, adjusting for variables such as cancer site, registry, age group, race/ethnicity, and year of diagnosis. Using the Tiwari technique, the same database was also used to determine the age‐standardized incidence rate (ASIR) of subtypes. The incidence data for 2020 were excluded from Joinpoint trends while displayed separately in illustrations.
Results
Over 2000–2019, most bladder cancer cases were urothelial carcinoma (92.99%), among non‐Hispanic Whites (84.48%) and those aged 70 to 84 years (45.72%). There was a significant decrease in the ASIR of bladder cancer across all races/ethnicities in both sexes within all age groups (Average annual percent change (AAPC): −0.95%; [−1.06, −0.83] for men and −1.02% [−1.21, −0.84] for women) over 2000–2019. The incidence rates decreased by 6.23% during the COVID‐19 pandemic. Also, the delay‐adjusted incidence rate of bladder cancer increased with advancing age.
Conclusions
Despite a decrease in ASIR of bladder cancer over 2000–2019, there are still a high number of incident cases, particularly among NHWs and the elderly. Future studies should investigate the underlying causes of bladder cancer incidence trends among demographic groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neurosciences Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
- Faculty of Medicine, Social Determinants of Health Research Center, Department of Community Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
- School of Medicine & Health Sciences, The George Washington University, Washington, District of Columbia, USA.
- School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Calaveras County Department of Health, Calaveras County, California, USA.
- Department of Community Medicine, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
ORCID-Profile: Seyed Ehsan Mousavi, Ryan Michael Antar, Armin Aslani, Pourya Shokri, Zahra Yekta, Amin Bateni, Nasser Shakhssalim, Seyed Aria Nejadghaderi
Zitieren
APA
Mousavi, S. E., Antar, R. M., Aslani, A., Shokri, P., Yekta, Z., Bateni, A., Shakhssalim, N., & Nejadghaderi, S. A. (2026). Bladder Cancer Incidence Trends in the United States From 2000 to 2020. Cancer Reports, 9(5). https://doi.org/10.1002/cnr2.70548
Vancouver
Mousavi SE, Antar RM, Aslani A, Shokri P, Yekta Z, Bateni A, et al. Bladder Cancer Incidence Trends in the United States From 2000 to 2020. Cancer Reports. 2026;9(5). doi:10.1002/cnr2.70548
BibTeX
@article{Mousavi2026,
author = {Mousavi, Seyed Ehsan and Antar, Ryan Michael and Aslani, Armin and Shokri, Pourya and Yekta, Zahra and Bateni, Amin and Shakhssalim, Nasser and Nejadghaderi, Seyed Aria},
title = {Bladder Cancer Incidence Trends in the United States From 2000 to 2020},
journal = {Cancer Reports},
year = {2026},
volume = {9},
number = {5},
doi = {10.1002/cnr2.70548}
}
EUVIMED